Insider Trading activities of Akcea Therapeutics, Inc. (AKCA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Akcea Therapeutics, Inc. (AKCA) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Akcea Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Akcea Therapeutics, Inc. since 2005. The reporting company's ticker symbol is AKCA. The reporting company's CIK number is 1662524.
The total value of stock buying since 2005 is $224,999,987.
The total value of stock sales since 2005 is $3,240,134.
The total value of stock option exercises since 2005 is $649,120.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Akcea Therapeutics, Inc. (AKCA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-07 0 $0 1,819 $42,782 0 $0
2019-04 0 $0 81,787 $2,606,500 81,787 $529,979
2019-03 0 $0 18,386 $590,852 18,386 $119,141
2018-04 10,666,666 $199,999,987 0 $0 0 $0
2017-07 3,125,000 $25,000,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Akcea Therapeutics, Inc. insiders (AKCA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-07-15 Boyce Sarah (President) Sale 1,819 23.52 42,782
2019-04-08 Goldberg Jeff Marc (Chief Operating Officer) Sale 20,000 31.72 634,420
2019-04-08 Goldberg Jeff Marc (Chief Operating Officer) Option Ex 20,000 6.48 129,600
2019-04-08 Soteropoulos Paula (Chief Executive Officer) Sale 1,787 32.17 57,480
2019-04-08 Soteropoulos Paula (Chief Executive Officer) Option Ex 1,787 6.48 11,579
2019-04-05 Goldberg Jeff Marc (Chief Operating Officer) Sale 30,000 31.71 951,300
2019-04-05 Goldberg Jeff Marc (Chief Operating Officer) Option Ex 30,000 6.48 194,400
2019-04-05 Soteropoulos Paula (Chief Executive Officer) Sale 30,000 32.11 963,300
2019-04-05 Soteropoulos Paula (Chief Executive Officer) Option Ex 30,000 6.48 194,400
2019-03-06 Soteropoulos Paula (Chief Executive Officer) Sale 18,386 32.14 590,852
2019-03-06 Soteropoulos Paula (Chief Executive Officer) Option Ex 18,386 6.48 119,141
2018-04-17 Ionis Pharmaceuticals Inc (10% Owner) Buy 10,666,666 18.75 199,999,987
2017-07-19 Ionis Pharmaceuticals Inc (10% Owner) Buy 3,125,000 8.00 25,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of AKCA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Akcea Therapeutics, Inc. (symbol AKCA, CIK number 1662524) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month